Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Glia
Journal
Overview
Identity
Overview
Publication Venue For
SRI-42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide-induced neuroinflammation
. 70:155-172.
2022
Astrocytes are necessary for blood–brain barrier maintenance in the adult mouse brain
. 69:436-472.
2021
K
ir
5.1-dependent CO
2
/H
+
-sensitive currents contribute to astrocyte heterogeneity across brain regions
. 69:310-325.
2021
Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL-34, and SCF in amyotrophic lateral sclerosis
. 68:1165-1181.
2020
Liver kinase B1 depletion from astrocytes worsens disease in a mouse model of multiple sclerosis
. 68:600-616.
2020
Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth
. 67:2424-2439.
2019
MicroRNA-31 is required for astrocyte specification
. 66:987-998.
2018
HuR promotes the molecular signature and phenotype of activated microglia: Implications for amyotrophic lateral sclerosis and other neurodegenerative diseases
. 65:945-963.
2017
Two modes of enteric gliotransmission differentially affect gut physiology
. 65:699-711.
2017
Plasmalemmal and mitochondrial Na
+
-Ca
2+
exchange in neuroglia
. 64:1646-1654.
2016
Spatio-temporal characteristics of metabotropic glutamate receptor 5 traffic at or near the plasma membrane in astrocytes
. 64:1050-1065.
2016
Loose excitation-secretion coupling in astrocytes
. 64:655-667.
2016
Expression of familial Alzheimer disease presenilin 1 gene attenuates vesicle traffic and reduces peptide secretion in cultured astrocytes devoid of pathologic tissue environment
. 64:317-329.
2016
Elevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease
. 63:2285-2297.
2015
GABAergic disinhibition and impaired KCC2 cotransporter activity underlie tumor-associated epilepsy
. 63:23-36.
2015
Transgenic analysis of GFAP promoter elements
. 61:1488-1499.
2013
Astroglial IFITM3 mediates neuronal impairments following neonatal immune challenge in mice.
. 61:679-693.
2013
Hyposmolality differentially and spatiotemporally modulates levels of glutamine synthetase and serine racemase in rat supraoptic nucleus
. 61:529-538.
2013
KSRP: A checkpoint for inflammatory cytokine production in astrocytes
. 60:1773-1784.
2012
Fingolimod-A sphingosine-like molecule inhibits vesicle mobility and secretion in astrocytes
. 60:1406-1416.
2012
Regulation of CCL20 expression in astrocytes by IL-6 and IL-17
. 60:771-781.
2012
Regulation of microglia effector functions by tumor necrosis factor signaling
. 60:189-202.
2012
CONTRIBUTION OF MYELOID SUPPRESSOR OF CYTOKINE SIGNALING 3 TO THE DEVELOPMENT OF NEUROINFLAMMATION
. 59:S25-S25.
2011
Alteration Of glial-neuronal metabolic interactions in a mouse model of Alexander disease
. 58:1228-1234.
2010
IL-27 inhibits OSM-mediated TNF-α and iNOS gene expression in microglia
. 58:1082-1093.
2010
Conditional deletion of β1-integrin in astroglia causes partial reactive gliosis
. 57:1630-1647.
2009
Dual regulation of Ca21-dependent glutamate release from astrocytes: Vesicular glutamate transporters and cytosolic glutamate levels
. 57:1296-1305.
2009
Molecular basis of oncostatin M-induced SOCS-3 expression in astrocytes
. 56:1250-1262.
2008
Ca
2+
entry through TRPC1 channels contributes to intracellular Ca
2+
dynamics and consequent glutamate release from rat astrocytes
. 56:821-835.
2008
GFAP promoter elements required for region-specific and astrocyte-specific expression
. 56:481-493.
2008
Vesicular transmitter release from astrocytes
. 54:700-715.
2006
HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1β
. 54:619-629.
2006
Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene
. 53:677-687.
2006
Functional expression of K
ir
4.1 channels in spinal cord astrocytes
. 53:516-528.
2006
Divergent effects of oncostatin M on astroglioma cells: Influence on cell proliferation, invasion, and expression of matrix metalloproteinases
. 53:191-200.
2006
Reactive oxygen species mediate chloroquine-induced expression of chemokines by human astroglial cells
. 47:9-20.
2004
GFAP: Functional implications gleaned from studies of genetically engineered mice
. 43:87-90.
2003
Oncostatin M enhances the expression of prostaglandin E
2
and cyclooxygenase-2 in astrocytes: Synergy with interleukin-1β, tumor necrosis factor-α, and bacterial lipopolysaccharide
. 42:433-446.
2003
Preparation of a monoclonal antibody to citrullinated epitopes: Its characterization and some applications to immunohistochemistry in human brain
. 37:328-336.
2002
Preparation of a monoclonal antibody to citrullinated epitopes: its characterization and some applications to immunohistochemistry in human brain.
. 37:328-336.
2002
Immune function of astrocytes
. 36:180-190.
2001
Transcriptional regulation of the intercellular adhesion molecule-1 gene by proinflammatory cytokines in human astrocytes.
. 25:21-32.
1999
Cleavage of membrane-associated ICAM-1 from astrocytes: Involvement of a metalloprotease
. 22:103-112.
1998
Transforming growth factor-beta inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes
. 22:171-179.
1998
Cytokines and tumors of the central nervous system
. 15:264-288.
1995
Interleukin 1‐β‐ and tumor necrosis factor‐α‐mediated regulation of ICAM‐1 gene expression in astrocytes requires protein kinase C activity
. 14:267-278.
1995
Microglial tyrosine phosphorylation systems in normal and degenerating brain
. 11:284-290.
1994
Interleukin‐1 and tumor necrosis factor‐mediated regulation of C3 gene expression in human astroglioma cells
. 7:225-236.
1993
Identity
International Standard Serial Number (issn)
0894-1491
Electronic International Standard Serial Number (eissn)
1098-1136